Morphofunctional cardiac parameters in middle-aged women with a history of hypertension during pregnancy

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background: The role of extragenital pregnancy-related complications in the development of late cardiovascular disease is being widely investigated. The prevalence of heart failure, specifically the form with preserved ejection fraction, is higher among females. The association between gestational hypertension and heart failure with preserved ejection fraction has been the subject of extensive research.

The aim of the study was to investigate the morphofunctional parameters of the heart in women with a history of gestational hypertension.

Methods: This study investigated the morphofunctional parameters of the heart in 102 women aged 45–59 years with a history of arterial hypertension during at least one completed pregnancy. The participants underwent transthoracic echocardiography and were then interviewed regarding their history of hypertension during pregnancy. Twenty-six women had a history of arterial hypertension during pregnancy, whereas 70 women did not. Subsequently, the echocardiographic parameters between the groups were compared.

Results: Among participants with a body mass index >25 kg/m2, the left ventricular myocardial mass index, which was adjusted for body surface area and height, was significantly higher in the those with a history of hypertension during pregnancy than in those without hypertension (88.6 ± 24.3 vs. 71.7 ± 15.3; p = 0.002 and 44.6 ± 14.3 vs. 32.8 ± 42.4 ; p = 0.004, respectively). Mitral annulus velocity was lower in women with pregnancy-related hypertension, which is a characteristic of impaired left ventricular relaxation. The detection rate of diastolic dysfunction was higher in the group of women with hypertension during pregnancy: 10 (38.5%) compared to 12 (17.1%) (p = 0.03). Moreover, significant differences (p = 0.003) in epicardial adipose tissue thickness were identified: 7.5 (5.5; 9) mm in the group of women with hypertension during pregnancy compared to 5 (4; 7) mm in those without.

Conclusions: In middle-aged women, the most pronounced changes were observed in diastolic dysfunction parameters and in cardiac morphometric characteristics. Furthermore, hypertension complications during pregnancy influence epicardial adipose tissue thickness, a key predictor of cardiovascular complications.

Full Text

Restricted Access

About the authors

Maxim I. Shperling

National Medical Research Center for Therapy and Preventive Medicine

Author for correspondence.
Email: mersisaid@yandex.ru
ORCID iD: 0000-0002-3274-2290
SPIN-code: 7658-7348

junior research assistant

Russian Federation, Moscow

Vasilisa M. Kosulina

National Medical Research Center for Therapy and Preventive Medicine

Email: vasilisa.kosulina@mail.ru
ORCID iD: 0009-0008-3682-3216

clinical resident

Russian Federation, Moscow

Olga N. Dzhioeva

National Medical Research Center for Therapy and Preventive Medicine

Email: dzhioevaon@gmail.com
ORCID iD: 0000-0002-5384-3795
SPIN-code: 1803-5454

MD, Dr. Sci. (Medicine)

Russian Federation, Moscow

References

  1. Mancia G, Kreutz R, Brunström M, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41(12):1874–2071. EDN: WRIBRQ doi: 10.1097/HJH.0000000000003480
  2. McEvoy JW, McCarthy CP, Bruno RM, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024;45(38):3912–4018. EDN: EEKZLN doi: 10.1093/eurheartj/ehae178
  3. Stolfo D, Uijl A, Vedin O, et al. Sex-based differences in heart failure across the ejection fraction spectrum: phenotyping, and prognostic and therapeutic implications. JACC Heart Failure. 2019;7(6):505–515. doi: 10.1016/j.jchf.2019.03.011
  4. Briller JE, Mogos MF, Muchira JM, et al. Pregnancy associated heart failure with preserved ejection fraction: risk factors and maternal morbidity. J Card Fail. 2021;27(2):143–152. EDN: SQUXMV doi: 10.1016/j.cardfail.2020.12.020
  5. Hansen AL, Søndergaard MM, Hlatky MA, et al. Adverse pregnancy outcomes and incident heart failure in the women’s health initiative. JAMA Netw Open. 2021;4(12):e2138071. EDN: IVLTTL doi: 10.1001/jamanetworkopen.2021.38071
  6. Lane-Cordova Abbi D, Khan SS, Grobman WA, et al. Long-term cardiovascular risks associated with adverse pregnancy outcomes. J Am Coll Cardiol. 2019;73(16):2106–2116. doi: 10.1016/j.jacc.2018.12.092
  7. Shahul S, Medvedofsky D, Wenger JB, et al. Circulating antiangiogenic factors and myocardial dysfunction in hypertensive disorders of pregnancy. Hypertension. 2016;67(6):1273–1280. doi: 10.1161/HYPERTENSIONAHA.116.07252
  8. Redfield MM, Borlaug BA. Heart failure with preserved ejection fraction: a review. JAMA. 2023;329(10):827–838. doi: 10.1001/jama.2023.2020
  9. Shakhnovich PG, Zakharova AI, Cherkashin DV, et al. Diastolic myocardium dysfunction: echocardiographic phenomenon or type of heart failure? Bulletin of the Russian Military Medical Academy. 2015;(3):54–57. EDN: VSTUSX
  10. Schulz A, Backhaus SJ, Lange T, et al. Impact of epicardial adipose tissue on cardiac function and morphology in patients with diastolic dysfunction. ESC Heart Fail. 2024;11(4):2013–2022. EDN: CIPZPO doi: 10.1002/ehf2.14744
  11. Galyavich AS, Tereshchenko SN, Uskach TM, et al. Chronic heart failure. Clinical recommendations 2024. Russian Journal of Cardiology. 2024;29(11):6162. EDN: WKIDLJ doi: 10.15829/1560-4071-2024-6162. EDN WKIDLJ
  12. Cohen JB, Schrauben SJ, Zhao L, et al. Clinical phenogroups in heart failure with preserved ejection fraction: detailed phenotypes, prognosis, and response to spironolactone. JACC Heart Failure. 2020;8(3):172–184. EDN: PGXXVB doi: 10.1016/j.jchf.2019.09.009
  13. Tromp J, MacDonald MR, Tay WT, et al. Heart failure with preserved ejection fraction in the young. Circulation. 2018;138(24):2763–2773. doi: 10.1161/CIRCULATIONAHA.118.034720
  14. Smiseth OA, Morris DA, Cardim N, et al. Multimodality imaging in patients with heart failure and preserved ejection fraction: an expert consensus document of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2022;23(2):e34–e61. EDN: TYKSGU doi: 10.1093/ehjci/jeab154
  15. Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the american society of echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016;29(4):277–314. EDN: WSISPD doi: 10.1016/j.echo.2016.01.011
  16. Drapkina OM, Angarsky RK, Rogozhkina EA, et al. Ultrasound-assisted assessment of visceral and subcutaneous adipose tissue thickness. Methodological guidelines. Cardiovascular Therapy and Prevention. 2023;22(3):3552. EDN: VBNLVL doi: 10.15829/1728-8800-2023-3552
  17. Boardman H, Lamata P, Lazdam M, et al. Variations in cardiovascular structure, function, and geometry in midlife associated with a history of hypertensive pregnancy. Hypertension. 2020;75(6):1542–1550. EDN: TSWRIM doi: 10.1161/HYPERTENSIONAHA.119.14530
  18. Dzhioeva ON, Timofeev YS, Metelskaya VA, et al. Role of epicardial adipose tissue in the pathogenesis of chronic inflammation in heart failure with preserved ejection fraction. Cardiovascular Therapy and Prevention. 2024;23(3):3928. EDN: DGYKKN doi: 10.15829/1728-8800-2024-3928
  19. Mikhailov AA, Khalimov YS, Gaiduk SV, et al. The role of adipokines in the development of adipose tissue dysfunction and other metabolic disorders. Bulletin of the Russian Military Medical Academy. 2022;24(1):209–218. EDN: RVOWXE doi: 10.17816/brmma103946
  20. Wang J, Li C, Li W, et al. Epicardial adipose tissue thickness associated with preeclampsia and birth weight in early pregnancy. Hypertens Pregnanсу. 2024;43(1):2390531. EDN: ANOLBH doi: 10.1080/10641955.2024.2390531

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Comparison of echocardiographic parameters between the groups: *p < 0,05; **p < 0,01; ns, nonsignificant difference; ИММЛЖ, left ventricular myocardial mass index; ИОЛП, left atrial volume index

Download (201KB)

Copyright (c) 2025 Eco-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 77762 от 10.02.2020.